Massachusetts General Hospital researchers complete first study comparing commonly used type 2 diabetes medications.
Diabetes Clinical Center
Diabetes Treatment Center
50 Staniford Street, Third Floor, Suite 340
Boston, MA 2114
Weekdays, 8:30 am–5:00 pm,
Closed 12:00 – 1:00 pm
After hours: Call 617-726-2000 for the diabetes MD on call
Your primary care physician is responsible for arranging all of your medical care, including referrals to specialists. If you think you need to see a specialist, please call us at 617-726-8722.
We accept most major insurance and managed care plans. Please confirm that we accept your plan before your first visit or when you change carriers. If you are required to choose a primary care physician, please make sure to name a Mass General Diabetes/Internist doctor.
Your physician will send most laboratory results directly to you. In case of an urgent result, a physician will call you as soon as possible. If you have any questions about your results, please call 617-726-8722. If you would like to sign up for Patient Gateway to access your results over the internet, please see someone at the front desk on your next visit.
To refill a prescription during center hours, call us at 617-726-8722.
Please have on hand your:
- Unit number and date of birth
- The name of your medication
- The dosage
- The telephone number of the pharmacy you would like to use
Please allow 48 hours to process your prescription.
Children & Adolescents
The Pediatric Endocrinology Unit at MassGeneral Hospital for Children provides care for children and adolescents with diabetes.
Explore This Center
How We Work
With a closely integrated treatment center and clinical research center, we aim to develop new treatments and provide the highest quality care for people with diabetes, pre-diabetes, and associated disorders. The ultimate goal of our work is to cure diabetes. However, until cures are developed, we offer the most advanced comprehensive therapy available for Type 1 and Type 2 diabetes and for the complications associated with diabetes. We also offer evaluation of rarer forms of diabetes including monogenic diabetes and Maturity Onset Diabetes of the Young (MODY).
About This Program
The Diabetes Clinical Center currently handles approximately 10,000 patient visits per year. The usual age range for our patients begins at age 18; the Pediatric Endocrinology Unit and Diabetes Center at MassGeneral Hospital for Children provides care for children and adolescents with diabetes. In addition to treating the metabolic abnormalities of approximately 2500 adults with type 1 and type 2 diabetes, the staff focuses on prevention of complications and rapid, effective treatment of those complications should they occur. The associated medical problems of obesity, pre-diabetes and metabolic syndrome, dyslipidemia, hypertension, eye, kidney, nerve, and cardiovascular disease are all addressed by the clinical staff.
In collaboration with other Mass General experts in renal disease, cardiology, podiatry and orthopedics, neurology, and vascular surgery, and retinal specialists and other ophthalmologists from the Mass Eye and Ear Infirmary and other specialty ophthalmology groups, comprehensive medical care is provided to all of our patients. The Diabetes Clinical Center staff includes 15 physicians, all of whom are Harvard Faculty, fellows who are training in endocrinology, diabetes and metabolism, highly experienced diabetes nurse practitioners, nurse certified diabetes educators and dietitians, physician assistants, and a highly committed and experienced support staff.
The center provides consultation about methods of glucose monitoring, injections and medication. On-site services include:
- Dietary and behavioral counseling
- Diabetes teaching provided by certified diabetes educators and nurse practitioners
First-rate Clinical Care Fortified by Cutting Edge Clinical Research
Many of the modern-day therapies have been developed at the Mass General Diabetes Clinical Research Center. Patients who attend the Diabetes Clinical Center often participate in research studies. When new therapies are developed, tested, and proved to be beneficial, the Mass General Diabetes Center patients are often the first to benefit from their use. The combination of a clinical treatment center and research center sharing space “under one roof” results in a highly effective and efficient setting for clinical research and clinical care.
Related News and Articles
- Press Release
- Aug | 15 | 2022
Multiple Shots of the Bacillus Calmette-Guerin (BCG) Vaccine Protect Patients with Type 1 Diabetes from COVID-19
In a double blind, placebo controlled trial, BCG vaccinated type 1 diabetics had significantly lower rates of infection and illness.
- Press Release
- May | 13 | 2022
Clinical trial is planned based on results from preclinical study.
- Press Release
- Feb | 24 | 2022
Newly diagnosed diabetes in patients with COVID-19 may simply be a transitory form of the blood sugar disorder
Researchers from Mass General shed light on whether newly diagnosed diabetes in COVID-19 patients is truly new or merely previously undiagnosed
- Nov | 16 | 2021
In this presentation from November 16, 2021, Tiffany Soper, FNP, CDE, and Briana Kilduff, RN, BSN, of the Mass General Diabetes Center review what type 2 diabetes is and discuss strategies to manage your glucose levels to prevent complications.
- Oct | 12 | 2021
Blocking serum- and glucocorticoid-regulated kinase may overcome insulin resistance, a hallmark of the disease.